> Back to EJC

Recent editions

  • October 2016
    Ruth Muschel on a new target for treatments for colorectal cancer.
  • September 2016
    Freddie Hamdy on the effectiveness of treatments for prostate cancer.
  • August 2016
    Moshe Oren discusses the effects of the microenvironment on cancer cells.
  • July 2016
    Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer.
  • June 2016
    Key advances in clinical trials.
  • May 2016
    Mark Lemmon on the underlying biochemistry of cancer.
  • April 2016
    Roger Stupp on using alternating electric fields as treatment.
  • March 2016
    Charlotte Vrinten on public perception of deaths from cancer.
  • February 2016
    Guillermo Garcia-Manero on myelodysplastic syndromes (MDS).
  • December 2015/January 2016
    Nazneen Rahman on germline genetic screening in ovarian cancer.
  • November 2015
    Caroline Robert on new developments in immunotherapy.

> All 2015 Editions

> All 2014 Editions

> All 2013 Editions

> All 2012 Editions

> All 2011 Editions

EJC News Focus – January 2013

Loading EJC News Focus video

Predictions in Cancer for 2013

What will be the big news in your field in 2013? The availability of new drugs, perhaps? Long awaited phase III data which could set research on a new tack? Or the spiralling costs that will effectively block patients’ access to new treatment approaches? In this month’s EJC News Focus, Helen Saul asks Mary O’Brien, Richard Marais, Roger Stupp, Manuela Schmidinger and David Cameron what they expect to be the key issues in their field in the coming year.